Thrombophilia risk factors evaluation in a group of Italian patients with deep venous thrombosis;Valutazione del rischio trombofilico in una coorte di pazienti con trombosi venosa profonda

Recenti Progressi in Medicina

Volumn 99, Issue 7-8, 2008, Pages 348-353

  Valverde, Sara ^a   Antico, Francesco ^a   Trabuio, Ernesto ^a   Basso, Daniela ^b   Navaglia, Filippo ^b   Orlandini, Elisa ^a   Giacomini, Alda ^a   Manoni, Fabio ^a   Gessoni, Gianluca ^a  

^a Ospedale Civile   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Anti phospholipids auto antibodies; APC resistance; Factor V Leiden; Risk factors; Thrombophilia; Venous thrombosis

Indexed keywords

ACTIVATED PROTEIN C; PHOSPHOLIPID ANTIBODY;

ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; RISK FACTOR; THROMBOPHILIA;

ACTIVATED PROTEIN C RESISTANCE; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, ANTIPHOSPHOLIPID; COHORT STUDIES; DATA INTERPRETATION, STATISTICAL; FACTOR V; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; POINT MUTATION; RISK FACTORS; THROMBOPHILIA; VENOUS THROMBOSIS;

EID: 49449102758     PISSN: 00341193     EISSN: 00341193     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Tripodi A, Mannucci P. Laboratory investigation of thrombophilia. Clin Chem 2001; 47: 1597-606.
2. Somma J, Sussman I, Rand J. An evaluation of thrombophilia screening in an urban tertiary care medical center: a "real word" experience. Am J Clin Pathol 2006; 126: 1-8.
3. LeagueS, Hooper W. Molecular diagnosis of inherited thrombosis. Clin Lab Sci 2005; 18: 271-9.
4. Moll S. Thrombophilias: practical implications and testing caveat. J Thromb Thrombolysis 2006; 21: 7-15.
5. Wilmer M, Stocker C, Buhler B, Conell B, Calatzis A. Improved distinction of factor V wild-type anf Factor V Leiden using a novel prothrombin based activated Protein C resistance assay. Am J Clin Pathol 2004; 122: 836-42.
6. Schoni R. The use of snake venom derived compounds for new functional test kits in the field of haemostasis. Pathophysiol Haemost Thromb 2005; 34: 234-40.
7. Valverde S, Gessoni G, Canistro R, Basso D, Navaglia F. Valutazione di un esame funzionale basato sul tempo di protrombina nello studio della resistenza alia proteina C attivata. Bioc Clin 2007; 31/6: 567-72.
8. De Stefano V, Rossi E, Paciaroni K, Leone G. Screening for inherited thrombophilia: indications and therapeutic implications. Haematologica 2002; 87: 1095-1108.
9. Paschoa A, Guillaumon A. Impact of screening on thrombophilia for patients with venous thrombosis. Int Angiol 2006; 25: 52-9.
10. Franchini M, Veneri D, Salvagno G, Manzato F, Lippi G. Inherited thrombophilia. Crit Rev Clin Lab Sci 2006; 43: 249-50.
11. Vig S, Chitolie A, Bevan D, Dormandy J, Thompson M, Halliday A. The prevalence of thrombophilia in patients with symptomatic peripheral vascular disease. Br J Surg 2006; 93: 577-81.
12. Bauduer F, Lacombe D. Factor V Leiden, prothrombin 20210A, methlylene tetra hydrofolate reductase 677T and population genetics. Mol Genet Metab 2005; 86: 91-9.
13. Schoni R, Quehenberger P, Wu J, Wilmer M. Clinical evaluation of a new functional test for detection of activated protein C resistance Pefakit APC-R Factor V Leiden at two centers in Europe and the USA. Thromb Res 2007; 119: 17-26.
14. Tripodi A. Issues concerning the laboratory investigations of inherited thrombophilia. Mol Diagn 2005; 9/4: 181-6.
15. Gessoni G, Valverse S, Canistro R, Trabuio E, Antico E, Manoni F. Laboratory assessment of hypercoagulable state: a study in a group of patients with venous thromboembolism born in Chioggia. Minerva Medica 2007; 98: 89-93.
16. Zoller B, Garcia de Frutos P, Dahlback B. Thrombophilia as a multigenic disease. Haematologica 1999; 84: 59-70.
17. Heit J. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 2006; 21: 23-9.